Columbia Research Enhanced Value ETF
REVS
9 hedge funds and large institutions have $3.54M invested in Columbia Research Enhanced Value ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 9 → 9 (0)
46.67% less ownership
Funds ownership: 69.1% → 22.43% (-47%)
74% less capital invested
Capital invested by funds: $13.8M → $3.54M (-$10.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$284K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$30.4K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$19.9K |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
+$9.57K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARG
Advisory Resource Group
Tulsa,
Oklahoma
|
-$10.3M |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
-$16.2K |
| 3 |
Morgan Stanley
New York
|
-$2.73K |
REVS Hedge Fund Activity: Q3 2022 in Review
9 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q3 2022, worth a combined $3.54M — down 74% from $13.8M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new REVS positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $284K. The largest seller was Advisory Resource Group, exiting entirely with an estimated $10.3M sold.
- 9 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $3.54M of Columbia Research Enhanced Value ETF stock for Q3 2022, down 74% quarter-over-quarter.
- 2 funds opened new Columbia Research Enhanced Value ETF positions in Q3 2022 and 1 closed out, a net change of +1 holder.
- The largest Columbia Research Enhanced Value ETF buyer in Q3 2022 was Citadel Advisors, an estimated $284K added.
- The largest Columbia Research Enhanced Value ETF seller in Q3 2022 was Advisory Resource Group, an estimated $10.3M sold.
Based on aggregated 13F filings for Q3 2022.